NCT07525037Not yet recruiting
Chinese, Overweight or Obesity, Real-World Registry Study
Chinese Registry of Overweight or Obesity, a Multicenter Real-World Registry Study on Clinical Management - CROWN Study
Source: ClinicalTrials.gov · Last updated 13 Apr 2026
Brief summary (registry, in English)
This study will enroll 10,000 patients with obesity, with the participation of approximately 50 medical institutions nationwide. At baseline, demographic data, physical examinations, multiple laboratory tests (including complete blood count, urinalysis, liver/renal function, electrolytes, thyroid function panel \[3 items\], urine albumin/creatinine ratio, fasting glucose, fasting C-peptide, fasting insulin, HbA1c, blood lipids, etc.) and hepatic elasticity ultrasound will be performed. Patients will receive weight-loss therapy in routine clinical practice. Data on clinic visits, adverse events, and changes in therapeutic regimens will be centrally collected by investigators or their authorized representatives at Week 26 and Week 52.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 10000 (estimated)
- First submitted
- 18 Mar 2026
- Start date
- 30 May 2026
- Primary completion date
- Dec 2027
- Lead sponsor
- Chinese PLA General Hospital
- Diseases
- Obesity, Type 2 diabetes
- NCT number
- NCT07525037
What you commit to
- Study type: Observational
- Planned participants: 10000
- From 30 May 2026 to the primary completion date, Dec 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Having life-threatening comorbidities, with an expected lifespan of less than one year.
- Participating in an interventional trial that requires informed consent.
- Engaging in other organized weight loss programs or other clinical trials.
- Researchers identify any situation that may endanger the safety or compliance of the subjects.
- \-
Who the study is looking for
- According to local regulations, the subjects included in the study should meet the following criteria:
- Male or female patients aged 18 years or above
- Diagnosed with overweight or obesity, with a BMI of ≥ 24 kg/m²
- Willing and able to use weight management apps
- Willing and able to provide a written informed consent for participating in the study
- Patients who meet the instructions for weight loss medication and have no contraindications to non-pharmacological treatments -
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Chinese PLA General Hospital Coordinator of this site? Confirm its status | Haidian | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.